The benefit that patients with overactive bladder (OAB) experience with conservative management is an important aspect in the evaluation of this therapy.
The first-line options include behavioral interventions, and several techniques are available. Clinical research indicates amelioration of individual symptoms with these techniques, but few studies have shown a positive effect on health-related quality-of-life parameters. After failure of behavioral therapy or in combination with a training program, pharmacological therapy with anticholinergics is the next step. Extensive clinical research into different pharmacological compounds has shown significant effects on the symptomatic elements of OAB. The clinical relevance and the effects on quality-of-life parameters with pharmacological therapy have also been evaluated and show a significant effect on specific aspects. Recently, clinical research in conservative management of patients with OAB has focused more on evaluating patients' perceptions of their condition and the effects of treatment with patient-reported outcome instruments. Future studies should include these tools in the evaluation of any therapy in OAB.
Written by:
Van Kerrebroeck PE. Are you the author?
Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Reference: Curr Urol Rep. 2012 Jul 22. Epub ahead of print.
doi: 10.1007/s11934-012-0262-0
PubMed Abstract
PMID: 22821230
UroToday.com Overactive Bladder (OAB) Section